Valneva
Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya
637 employees · est. 2013 · Saint-herblain, France
Valneva is the older company (2014 vs 2013); Valneva is the larger of the two.
Side-by-Side Comparison
| Metric | Longeveron Inc | Valneva |
|---|---|---|
| Founded | ||
| Founded | 2014 | 2013 older |
| Headquarters | ||
| Headquarters | Miami, United States | Saint-herblain, France |
| Employees | ||
| Employees | 29 | 637 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Grant |
| Total Funding | ||
| Total Funding | $34.01M | $720.10M |
| Funding Rounds | ||
| Funding Rounds | 10 | 15 |
| Services | ||
| Services | Not tracked yet | Vaccine Research and Development, Manufacturing of Vaccines, Commercialization of Vaccines, Marketing and Distribution |
| Target Customers | ||
| Target Customers | Not tracked yet | Healthcare Providers, Travelers, Health Organizations, Governments, Investors |
| Taxonomy | ||
| Taxonomy | Cell-based Therapies, Clinical-stage Biotech, Regenerative Medicine, MSC Therapy, Aging-related Diseases, Clinical Trials, Lomecel-B™, Healthspan, Aging Frailty, Alzheimer's Disease, Hypoplastic Left Heart Syndrome, Regulatory Approvals, Immune System Function, Public Health Advancements | Specialty Vaccines, Infectious Disease Prevention, Prophylactic Vaccines, Vaccine Modalities, First-in-Class Vaccines, Only-in-Class Vaccines, Lyme Disease Vaccine, Chikungunya Vaccine, Travel Vaccines, Vaccine R&D, Vaccine Manufacturing, Clinical Development, Public Health Threats, Pfizer Partnership, Zika Virus Vaccine |
| Website | ||
| Website | longeveron.com | valneva.com |
About Longeveron Inc
Longeveron Inc is a biotechnology company that focuses on developing cellular therapies for aging-related and life-threatening conditions. The company's flagship product, Lomecel-B™, consists of culture-expanded medicinal signaling cells (MSCs) derived from the bone marrow of young healthy adult don...
About Valneva
Valneva, founded in 2013, is a France-based specialty vaccine company renowned for addressing infectious diseases with significant unmet needs. With a forward-thinking approach, the company prides itself on offering first-, best-, or only-in-class vaccine solutions. Their portfolio includes the worl...
We will tell you when either one moves
BounceWatch watches Longeveron Inc and Valneva for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Longeveron Inc and Valneva — by email.
Frequently Asked Questions
Compare Longeveron Inc with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Longeveron Inc on 13 Sep 2024, and Valneva on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.